Shelton Capital Management’s Ingevity NGVT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2020
Q1
Sell
-2,614
Closed -$228K 767
2019
Q4
$228K Sell
2,614
-209
-7% -$18.3K 0.01% 683
2019
Q3
$240K Hold
2,823
0.01% 652
2019
Q2
$297K Buy
2,823
+2,377
+533% +$239K 0.02% 535
2019
Q1
$4.22K Sell
446
-3,777
-89% -$379K 0.02% 621
2018
Q4
$353K Hold
4,223
0.02% 408
2018
Q3
$430K Buy
4,223
+435
+11% +$42K 0.02% 412
2018
Q2
$306K Hold
3,788
0.02% 550
2018
Q1
$279K Hold
3,788
0.02% 588
2017
Q4
$267K Hold
3,788
0.02% 649
2017
Q3
$237K Sell
3,788
-394
-9% -$23.3K 0.02% 702
2017
Q2
$240K Buy
4,182
+281
+7% +$16.5K 0.02% 713
2017
Q1
$237K Buy
3,901
+243
+7% +$13.7K 0.02% 712
2016
Q4
$201K Buy
+3,658
New +$175K 0.02% 834

Other funds holding NGVT

Shelton Capital Management's NGVT Position: Q1 2020 in Review

Shelton Capital Management sold out of Ingevity (NGVT) in Q1 2020, closing a stake of 2,614 shares — an estimated $228K sold.

Shelton Capital Management first reported a position in NGVT in Q4 2016 and held it in 13 quarters. The position peaked at $430K in Q3 2018. 272 funds tracked by Wall St. Rank hold NGVT as of Q1 2020.

  • Shelton Capital Management reported no remaining Ingevity position as of Q1 2020 after selling out during the quarter.
  • Shelton Capital Management sold 2,614 Ingevity shares in Q1 2020, an estimated $228K.
  • Shelton Capital Management first reported a position in Ingevity in Q4 2016 and held it in 13 quarters.
  • Shelton Capital Management's Ingevity position peaked at $430K in Q3 2018.
  • 272 funds tracked by Wall St. Rank held Ingevity as of Q1 2020.

Based on Shelton Capital Management's 13F filing for Q1 2020, filed 13 May 2020.